Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis

Yu-Mei Shen1, Jia-Feng Wu, Hong-Yuan Hsu

  • 1Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.

Insights

Fat-soluble vitamin deficiencies are prevalent in children with chronic cholestasis. An oral, absorbable formulation (OAFSV) demonstrated safety and potential efficacy in improving vitamin levels.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Nutritional Science

Background:

  • Fat-soluble vitamin (FSV) deficiencies are frequent complications in pediatric patients diagnosed with chronic cholestasis.
  • Current conventional supplementation strategies may not adequately address these deficiencies.

Purpose of the Study:

  • To assess the prevalence of FSV deficiencies in pediatric patients with chronic cholestasis under current management practices.
  • To evaluate the efficacy and safety of an oral, absorbable fat-soluble vitamin (OAFSV) formulation in this patient population.

Main Methods:

  • A cohort of 23 pediatric patients with various cholestatic conditions were studied.
  • Ten patients transitioned to OAFSV supplementation for 3 months, while plasma vitamin levels (A, D, E) and international normalized ratio (INR) were monitored.

Main Results:

  • High baseline deficiency rates for vitamins A (73.9%), D (81.8%), and E (91.3%) were observed. Patients with higher bilirubin levels showed universal deficiencies.
  • Following 3 months of OAFSV, deficiency rates for vitamins A, D, and E decreased from 80%, 100%, and 100% to 70%, 60%, and 60%, respectively.
  • No adverse events or overdose effects were reported with OAFSV supplementation.

Conclusions:

  • Pediatric patients with chronic cholestasis exhibit high rates of fat-soluble vitamin deficiencies despite current follow-up protocols.
  • Oral, absorbable fat-soluble vitamin (OAFSV) supplementation appears to be a safe and potentially effective therapeutic option for this vulnerable group.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...